Global E-Health Forum to Present Strategies, Solutions and Services

25 - 26 October 2010, Hamburg, Germany.
Healthcare systems all over the world are facing very similar challenges: demographic shifts, the impact of globalization and an increased burden of chronic diseases and expensive treatments, to mention some of the most important ones. The Global E-Health Forum will addresses these challenges. The first conference day at the Hamburg Chamber of Commerce will feature strategy and best practice presentation, workshops, discussion forums and an accompanying exhibition. The second day will be hosted by Asklepios Clinics. There, conference attendees may expect show cases, hands-on presentations and guided tours as well as a panel discussion titled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver". The official reception for the international audience will take place at the U.S. Consulate General.

"Countries all over the world are facing manifold challenges regarding their healthcare delivery. Due to limited budgets and increasing demand for high-quality healthcare services, new cost-efficient, reliable and interconnected systems need to be developed", explains Ljubisav Matejevic, founder and director of the Global E-Health Forum. "This is the reason why after three Baltic Conferences on E-Health (2007-2009), we have decided to found the Global E-Health Forum," continues Ljubisav Matejevic. "E-health, meaning the application of information and communication technologies across the whole range of functions that affect the health sector, can make an important contribution to ensure a high-quality healthcare service for all citizens now and in the future.”

In keynote presentations, speakers from the U.S., Europe and New Zealand will explain their e-health strategies. Harry Reynolds, chairman of the National Committee on Vital and Health Statistics (NCVHS) and chairman of the Council for Affordable Quality Healthcare (CAQH) CORE Initiative will start this program session with his presentation titled "U.S. Health Reform: Significant Change, Varied Reaction, Opportunities Abound, and Outcome Uncertain".

The second program session will deal with best practices, for example presenting the hospital information system of Severance Cardiovascular Hospital in Seoul, South Korea. Other best practices featured will be a medical decision support system for general practitioners and interesting solutions regarding questions of quality management and process optimization.

The program will also include various breakout sessions with workshops and discussion forums where e.g. sustainable telemedicine services will be presented.

The organizers of the Global E-Health Forum - European Health Telematics Association (EHTEL), Hamburg Chamber of Commerce and IBM - have identified in Asklepios an excellent cooperation partner. Recognized as one of the most innovative leading hospital chains (the group oversees over 100 institutions, almost 40 day clinics, around 22,000 beds and 36,000 staff in Germany, Europe and the USA), Asklepios takes care of over one million patients every year. At Asklepios Clinics in Hamburg, attendees may expect more best practice solutions and hands-on experience. However, another important part will be the "services session" meaning the patients' and consumers' perspective / patient-centric e-health services. Uwe Poettgen, CIO of the Asklepios Group, will introduce this topic with a presentation entitled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver".

The primary aim of the English-language conference is to provide a cross-sector forum for approximately 200 representatives from hospitals and clinics, governments, health insurance organizations, service providers and the media. Policymakers, users, suppliers and implementation managers will have the opportunity to exchange views and experiences among all those involved in health management. The impact of globalization on healthcare systems and services will be discussed as well as the resulting requirements regarding interconnectivity, interoperability and standardization as well as the need for cross border co-operation.

Among the supporters of this year's conference are the European Association of Healthcare IT Managers, Koch-Mechnikov-Forum, German Hospital Society, U.S. Commercial Service, Finpro, Business Institute (Croatia), and FOM University of Applied Sciences.

For further information and registration, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

Pfizer receives FDA approval for SUTENT® (sunitini…

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

New US study reveals key reasons why millions of p…

Few of the more than 90 million Americans(1) with obesity are seeking and receiving long-term obesity care, according to new data from the Awareness, Care and Treatment I...

Efficacy and safety maintained in patients who swi…

Boehringer Ingelheim today announced one-year data from VOLTAIRE®-RA, a pivotal Phase III clinical trial comparing Cyltezo® (adalimumab-adbm) and reference product Humira...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]